HTGMQ

0.00010.00%
MG

Michelle Griffin

Independent Director

Ms. Michelle R. Griffin, MBA, serves as Director at Adaptive Biotechnologies Corporation since March 2019. Ms. Griffin serves as an Operations Consultant at OncoGenex Pharmaceuticals, Inc. Ms. Griffin serves as Principal of the Pacific Biotechnology Consulting Group. She served as an Independent Director at Chinook Therapeutics, Inc. since October 2020 until August 11, 2023. She served as an Executive Vice President of Operations at OncoGenex Pharmaceuticals, Inc. from January 3, 2011 to March 31, 2013 and also its Chief Financial Officer and Principal Accounting Officer, Secretary and Treasurer from May 31, 2012 to February 1, 2013. She served as the Chief Operating Officer of Trubion Pharmaceuticals Inc., (alternate name Emergent Product Development Seattle LLC) since November 16, 2009 until October 2010, Senior Vice President since February 2006, Chief Financial Officer from February 2006 to November 16, 2009, Treasurer from July 2007 to November 16, 2009 and Principal Accounting Officer until November 16, 2009. She served as Senior Vice President and Chief Financial Officer of Dendreon Corp., from August 17, 2005 to January 2006 and served as Head of its Manufacturing Operations since November 2005. She served as Chief Financial Officer of GSK Biologicals Seattle from January 1998 to July 2005, Senior Vice President from January 2001 to July 2005 and also as its Principal Accounting Officer until July 2005. She was at GSK Biologicals Seattle (formerly, Corixa Corporation.,) until 2005. Ms. Griffin served as acting chief executive at Trubion Pharmaceuticals, Inc. Ms. Griffin began her career in the biopharmaceuticals industry in 1994 at Corixa Corp. (Nasdaq: CRXA) and served as its chief financial officer from its IPO in 1997 until 2005 when Corixa was acquired by GlaxoSmithKline plc. Ms. Griffin joined Corixa as Controller in 1994 and served as Vice President of Finance and Administration from February 1997 to January 1998. She served GSK Biologicals Seattle’s Vice President and Chief Financial Officer from January 1998 to December 2000. She served as Director of Finance and Administration at GSK Biologicals Seattle from 1996 to February 1997. She served as Chief Financial Officer and Vice President of GenQuest, Inc. She worked as a Consultant to Corixa from November 1994 to March 1995. Prior to joining Corixa, Ms. Griffin held finance and strategic planning positions at The Boeing Company. Prior to entering the biotechnology field, she served for several years in numerous management positions at aerospace giant The Boeing Company and prior to that, as a Research Analyst at Cypress International Inc., a Washington, D.C.-based high-technology consulting firm. She had been a Director of PhaseRx, Inc. since February 9, 2016 until 2018. She has also served chair of the board of directors for Universal Cells, Inc. from 2017 until its acquisition by Astellas Pharma Inc. in 2018. She had been a Director of Virginia Mason Health System and Virginia Mason Franciscan Health since 2014 until 2018. She has been Independent Director of HTG Molecular Diagnostics, Inc., since August 15, 2018. She had been an Independent Director of Acer Therapeutics Inc. since September 2017 until November 17, 2023. She served as a Director of OncoGenex Pharmaceuticals, Inc. from 2008 to January 3, 2011. Ms. Griffin served as a Member of the Board of Directors for Polynoma LLC from 2012 to 2014. Ms. Griffin served as an Independent Director of Sonus Pharmaceuticals Inc., since May 6, 2004 to 2008. She served as Director of the Washington Biotechnology and BioMedical Association. She Chairs the Executive Advisory Board of the Albers School of Business and Economics at Seattle University in Seattle, Wash. She received Bachelor of Science degree in marketing and statistics from George Mason University in Fairfax, Virginia and an MBA in Finance and International Business from Seattle University. She also has received a post-graduate certificate in accounting from Seattle University. Ms. Griffin received her Certified Public Accountant Certification from the State of Washington.

Positions